Kazazian HH, Orkin SH, Boehm CD, Sexton JP, Antonarakis SE. beta-Thalassemia due to a deletion of the nucleotide which is substituted in the beta S-globin gene. Am J Hum Genet. 1983;35(5):1028–33.

CAS  PubMed  PubMed Central  Google Scholar 

Data & Statistics on Sickle Cell Disease. Centers for Disease Control and Prevention. 2022 Available from: https://www.cdc.gov/ncbddd/sicklecell/data.html

Hockham C, Bhatt S, Colah R, Mukherjee MB, Penman BS, Gupta S, et al. The spatial epidemiology of sickle-cell anaemia in India. Sci Rep. 2018;8(1):17685.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva-Junior AL, Garcia NP, Cardoso EC, Dias S, Tarragô AM, Fraiji NA, et al. Immunological hallmarks of inflammatory status in vaso-occlusive crisis of sickle cell anemia patients. Front Immunol. 2021;12: 559925.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nader E, Romana M, Connes P. The red blood cell—inflammation vicious circle in sickle cell disease. Front Immunol. 2020;11(454):1–11.

Google Scholar 

Ndefo UA, Maxwell AE, Nguyen H, Chiobi TL. Pharmacological management of sickle cell disease. Pharm Ther. 2008;33(4):238–43.

Google Scholar 

Fatahi S, Pezeshki M, Mousavi SM, Teymouri A, Rahmani J, Kord Varkaneh H, et al. Effects of folic acid supplementation on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis NMCD. 2019;29(5):432–9.

Article  CAS  PubMed  Google Scholar 

Paniz C, Bertinato JF, Lucena MR, De Carli E, da Amorim PM, Gomes GW, et al. A daily dose of 5 mg folic acid for 90 days is associated with increased serum unmetabolized folic acid and reduced natural killer cell cytotoxicity in healthy Brazilian adults. J Nutr. 2017;147(9):1677–85.

Article  CAS  PubMed  Google Scholar 

Allali S, Maciel TT, Hermine O, de Montalembert M. Innate immune cells, major protagonists of sickle cell disease pathophysiology. Haematologica. 2020;105(2):273–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asbaghi O, Ashtary-Larky D, Bagheri R, Moosavian SP, Nazarian B, Afrisham R, et al. Effects of folic acid supplementation on inflammatory markers: a grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Nutrients. 2021;13(7):2327.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalmbach R, Paul L, Selhub J. Determination of unmetabolized folic acid in human plasma using affinity HPLC12345. Am J Clin Nutr. 2011;94(1):343–7.

Article  Google Scholar 

Williams BA, Mayer C, McCartney H, Devlin AM, Lamers Y, Vercauteren SM, et al. Detectable unmetabolized folic acid and elevated folate concentrations in folic acid-supplemented canadian children with sickle cell disease. Front Nutr. 2021;8: 642306.

Article  PubMed  PubMed Central  Google Scholar 

Ceglie G, Di Mauro M, Tarissi De Jacobis I, de Gennaro F, Quaranta M, Baronci C, et al. Gender-related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study. Front Mol Biosci. 2019;6(140):1–5.

Google Scholar 

Udezue E, Girshab AM. Differences between males and females in adult sickle cell pain crisis in eastern Saudi Arabia. Ann Saudi Med. 2004;24(3):179–82.

Article  PubMed  PubMed Central  Google Scholar 

Panigrahi S, Patra PK, Khodiar PK. The screening and morbidity pattern of sickle cell anemia in Chhattisgarh. Indian J Hematol Blood Transfus Off J Indian Soc Hematol Blood Transfus. 2015;31(1):104–9.

Article  Google Scholar 

Omoti CE. Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crisis in Benin City. Nigeria Ann Afr Med. 2005;4(2):62–7.

Google Scholar 

Keikhaei B, Mohseni AR, Norouzirad R, Alinejadi M, Ghanbari S, Shiravi F, et al. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. Eur Cytokine Netw. 2013;24(1):45–52.

Article  CAS  PubMed  Google Scholar 

Sarray S, Saleh LR, Lisa Saldanha F, Al-Habboubi HH, Mahdi N, Almawi WY. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine. 2015;72(1):43–7.

Article  CAS  PubMed  Google Scholar 

Mohammed FA, Mahdi N, Sater MA, Al-Ola K, Almawi WY. The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease. Blood Cells Mol Dis. 2010;45(4):293–6.

Article  CAS  PubMed  Google Scholar 

Okocha C, Manafa P, Ozomba J, Ulasi T, Chukwuma G, Aneke J. C-reactive protein and disease outcome in nigerian sickle cell disease patients. Ann Med Health Sci Res. 2014;4(5):701–5.

Article  PubMed  PubMed Central  Google Scholar 

Akohoue SA, Shankar S, Milne GL, Morrow J, Chen KY, Ajayi WU, et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007;61(2):233–8.

Article  CAS  PubMed  Google Scholar 

Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr. 1997;65(6):1790–5.

Article  CAS  PubMed  Google Scholar 

Tam C, O’Connor D, Koren G. Circulating unmetabolized folic Acid: relationship to folate status and effect of supplementation. Obstet Gynecol Int. 2012. https://doi.org/10.1155/2012/485179.

Article  PubMed  PubMed Central  Google Scholar 

Bayer AL, Fraker CA. The folate cycle as a cause of natural killer cell dysfunction and viral etiology in type 1 diabetes. Front Endocrinol. 2017;8(315):1–11.

Google Scholar 

Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136(1):189–94.

Article  CAS  PubMed  Google Scholar 

Tang JS, Cait A, White RM, Arabshahi HJ, O’Sullivan D, Gasser O. MR1-dependence of unmetabolized folic acid side-effects. Front Immunol. 2022;9(13): 946713.

Article  Google Scholar